Received May 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | UNK | U7947AA | — |
| RV5 | ROTAVIRUS (ROTATEQ) | MERCK & CO. INC. | UNK | 2088619 | — |
HBP reported patient was administered ROTATEQ & VAXELIS during a temperature excursion.; This non-serious spontaneous safety report, with reference number 02796514 (interaction number: 02796419), was received by the partner on 29-APR-2025 and forwarded on 29-APR-2025, from other health professional. Due to the nature of the event, the causality between the event "HBP reported patient was administered ROTATEQ & VAXELIS during a temperature excursion" and Vaxelis was not applicable. Further information is expected.
Prophylaxis